Guardat en:
| Autor principal: | |
|---|---|
| Format: | Recurso digital |
| Idioma: | |
| Publicat: |
Zenodo
2026
|
| Matèries: | |
| Accés en línia: | https://doi.org/10.5281/zenodo.20174392 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Taula de continguts:
- Cross-titration is commonly recommended for switching from olanzapine to aripiprazole, allowing for gradual cessation of olanzapine while initiating aripiprazole over a 14-day period to maintain therapeutic efficacy.